The results obtained in this study may seem controversial in comparison to previously published results elsewhere, in which MRP2, CXCR4, and PD-L1 were reported to be associated with the poor prognosis of patients with various cancers when expressed at high levels. The gene discussed is CD274; the disease is cancer.